Cerebroprotein Hydrolysate for Injection
[Dosage Form] Freeze-dried powder for injection.
[Indications]
• Primary dementia (Alzheimer's senile dementia);
• Vascular dementia (eg multi-infarct dementia, etc) and cognitive dysfunction after mild and moderate stroke;
• Mixed dementia;
• Cerebral function disorders after cranial injuries.
[Specification] 30mg/vial, 60mg/vial.
[Originator] Ebewe Pharma, with brand name of “Cerebrolysin”.
[Highlights]
• Registered in India, Viet Nam, Georgia
2006-2025 上海博華國(guó)際展覽有限公司版權(quán)所有(保留一切權(quán)利)
滬ICP備05034851號(hào)-57